The report includes analysis of major segments of the global antimalarial market based on product type, application, and region. The report contains market research on different factors, such as market size, market share, industry competition and growth, and other quantitative information.
New York, United States – June 19, 2020 /MarketersMedia/ —
Antimalarial drugs refer to drugs used to prevent or treat malaria. Malaria makes people sick and fatal through several different degrees of pathological mechanisms. The purpose of treatment is to prevent death or long-term diseases caused by malaria, reduce the incidence of acute diseases, and completely eliminate infections so that they will not relapse.
Malaria is a malignant infectious disease with an extremely widespread epidemic and extremely high morbidity and mortality in the world. More than 500 million people are infected each year, and three million patients die. And more than half of the victims are children in Africa. The resistance of plasmodium falciparum resistance to artemisinin is a public health problem that urgently needs to be addressed, threatening the sustainability of the global malaria reduction effort. The delivery of malaria control products such as mosquito nets and insecticides has also hindered the development of the antimalarial market.
The main factors driving the growth of the antimalarial market include the rising prevalence of malaria in developing countries, which has led to an increase in the demand for antimalarial drugs. In addition, the government’s measures to increase health awareness, timely diagnosis and treatment to prevent the development of malaria from severe to death, and research on new antimalarial drugs are some other factors that promote market growth.
Get FREE Sample of Antimalarial Drug Market Report at:
https://www.globalmarketmonitor.com/request.php?type=3&rid=560866
The Major Players Profiled in This Report Include:
F. Hoffmann-La Roche Ltd.
Novartis AG
GlaxoSmithKline plc
Sanofi S.A.
Mayne Pharma Group Limited
King Pharmaceuticals, Inc.
Merck KGaA
Alvizia Health Care
Bayer
The Type and Application Analysis:
Type Outlook (Revenue, USD Million; 2014-2026):
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
Application Outlook (Revenue, USD Million; 2014-2026):
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Other
To Identify the Key Trends in the Industry, Click on the Link Below:
https://www.globalmarketmonitor.com/reports/560866-antimalarial-drug-market-report.html
According to data from the World Health Organization’s World Malaria Report 2019, among the population of the children of receiving antimalarial treatment, children who are treated in public hospitals are more likely to receive artemisinin-based combinations or combination medications slightly higher than formal private hospitals or the informal private sector, therefore, hospital pharmacies have the highest share of antimalarial drugs.
According to the World Health Organization’s World Malaria Report 2019, 19 countries in sub-Saharan Africa and India bear nearly 85% of the global malaria burden, and nearly 85% of global malaria deaths are concentrated in the African Region and India. It is expected that the demand for antimalarial drugs in Africa will continue to rise. In addition, the need for early diagnosis of malaria infections in this region will further promote the growth of anti-malarial drugs in the region.
Get the Complete Table of Content Immediately
Antimalarial Drug Report Table of Content:
Chapter 1 Report Overview
Chapter 2 Market Trends and Competitive Landscape
Chapter 3 Segmentation of Antimalarial Drug Market by Types
Chapter 4 Segmentation of Antimalarial Drug Market by End-Users
Chapter 5 Market Analysis by Major Regions
Chapter 6 Product Commodity of Antimalarial Drug Market in Major Countries
Chapter 7 North America Antimalarial Drug Landscape Analysis
Chapter 8 Europe Antimalarial Drug Landscape Analysis
Chapter 9 Asia Pacific Antimalarial Drug Landscape Analysis
Chapter 10 Latin America, Middle East & Africa Antimalarial Drug Landscape Analysis
Chapter 11 Major Players Profile
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Novartis AG
11.2.1 Novartis AG Profile and Recent Development
11.2.2 Market Performance
11.2.3 Product and Service Introduction
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Profile and Recent Development
11.3.2 Market Performance
11.3.3 Product and Service Introduction
…
Chapter 12 Data Source and Research Methodology
The List of Tables and Figures
Avail a FREE Sample to Know More About the Complete Report:
https://www.globalmarketmonitor.com/request.php?type=3&rid=560866
Available Customizations – Market Monitor offers customizations according to the company’s specific needs.
Antimalarial Drug Report Provide:
Potential opportunities and challenges analysis in the Antimalarial Drug market.
Current and future market outlook in the developed and emerging regional markets.
Detailed analysis of the segment that is expected to dominate the market.
Regions that are expected to witness the fastest growth during the forecast period.
Identify the latest developments, market shares, and strategies employed by the major market players.
Comprehensive & in-depth research and after-sales warranty by Global Market Monitor.
Analysis of Influences of COVID-19 to the present and future Antimalarial Drug market and related industry.
Contact Info:
Name: Quella
Email: Send Email
Organization: Market Monitor
Address: One Pierrepont Plaza, 14th Floor, 300 Cadman Plaza W,Brooklyn, NY 11201, USA
Phone: + 1 (347) 467 7721
Website: https://www.globalmarketmonitor.com/
Source: MarketersMedia
Release ID: 88964459
